Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
163 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Saint Joseph'S Hospital and Medical Center
Phoenix, Arizona, United States
- John Muir Medical Center-Concord Campus
Concord, California, United States
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- University of California San Diego
San Diego, California, United States
- John Muir Medical Center-Walnut Creek
Walnut Creek, California, United States
- University of Colorado Hospital
Aurora, Colorado, United States
- University of Connecticut
Farmington, Connecticut, United States
- Hartford Hospital
Hartford, Connecticut, United States
- Smilow Cancer Hospital Care Center at Saint Francis
Hartford, Connecticut, United States
- the Hospital of Central Connecticut
New Britain, Connecticut, United States
- Beebe Medical Center
Lewes, Delaware, United States
- Christiana Care Health System-Christiana Hospital
Newark, Delaware, United States
- Piedmont Hospital
Atlanta, Georgia, United States
- Lewis Cancer and Research Pavilion at Saint Joseph'S/candler
Savannah, Georgia, United States
- Saint Alphonsus Cancer Care Center-Boise
Boise, Idaho, United States
- Rush University Medical Center
Chicago, Illinois, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- Cancer Care Specialists of Illinois - Decatur
Decatur, Illinois, United States
- Decatur Memorial Hospital
Decatur, Illinois, United States
- Crossroads Cancer Center
Effingham, Illinois, United States
- Sudarshan K Sharma Md Limited-Gynecologic Oncology
Hinsdale, Illinois, United States
- Uc Comprehensive Cancer Center at Silver Cross
New Lenox, Illinois, United States
- Indiana University/melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
- Saint Vincent Hospital and Health Care Center
Indianapolis, Indiana, United States
- Mcfarland Clinic Pc - Ames
Ames, Iowa, United States
- Iowa Lutheran Hospital
Des Moines, Iowa, United States
- Iowa Methodist Medical Center
Des Moines, Iowa, United States
- Medical Oncology and Hematology Associates-Des Moines
Des Moines, Iowa, United States
- Medical Oncology and Hematology Associates-Laurel
Des Moines, Iowa, United States
- Mercy Medical Center - Des Moines
Des Moines, Iowa, United States
- Cancer Center of Kansas - Chanute
Chanute, Kansas, United States
- Cancer Center of Kansas - Dodge City
Dodge City, Kansas, United States
- Cancer Center of Kansas - El Dorado
El Dorado, Kansas, United States
- Cancer Center of Kansas - Fort Scott
Fort Scott, Kansas, United States
- Cancer Center of Kansas-Independence
Independence, Kansas, United States
- Cancer Center of Kansas-Kingman
Kingman, Kansas, United States
- Cancer Center of Kansas-Liberal
Liberal, Kansas, United States
- Cancer Center of Kansas - Newton
Newton, Kansas, United States
- Cancer Center of Kansas - Parsons
Parsons, Kansas, United States
- Cancer Center of Kansas - Pratt
Pratt, Kansas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 Dec 2010
- Primary completion
- 1 Sept 2011
- Completion
- 31 Aug 2016
- Last update posted
- 20 Oct 2021
- Registered enrollment
- 58
- Registry id
- NCT00888615
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.